Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Göttlicher M[au]:

Metal release and cell biological compatibility of beta-type Ti-40Nb containing indium. Pilz S et al. J Biomed Mater Res B Appl Biomater. (2018)

Functionalization of Ti-40Nb implant material with strontium by reactive sputtering. Göttlicher M et al. Biomater Res. (2017)

The dioxin and peroxisome proliferator-activated receptors: nuclear receptors in search of endogenous ligands. Poellinger L et al. Trends Pharmacol Sci. (1992)

Search results

Items: 1 to 50 of 62

1.

Functionalization of Ti-40Nb implant material with strontium by reactive sputtering.

Göttlicher M, Rohnke M, Moryson Y, Thomas J, Sann J, Lode A, Schumacher M, Schmidt R, Pilz S, Gebert A, Gemming T, Janek J.

Biomater Res. 2017 Oct 10;21:18. doi: 10.1186/s40824-017-0104-8. eCollection 2017.

2.

Metal release and cell biological compatibility of beta-type Ti-40Nb containing indium.

Pilz S, Gebert A, Voss A, Oswald S, Göttlicher M, Hempel U, Eckert J, Rohnke M, Janek J, Calin M.

J Biomed Mater Res B Appl Biomater. 2018 Jul;106(5):1686-1697. doi: 10.1002/jbm.b.33976. Epub 2017 Aug 26.

PMID:
28842963
3.

Valproic acid in combination with all-trans retinoic acid and intensive therapy for acute myeloid leukemia in older patients.

Tassara M, Döhner K, Brossart P, Held G, Götze K, Horst HA, Ringhoffer M, Köhne CH, Kremers S, Raghavachar A, Wulf G, Kirchen H, Nachbaur D, Derigs HG, Wattad M, Koller E, Brugger W, Matzdorff A, Greil R, Heil G, Paschka P, Gaidzik VI, Göttlicher M, Döhner H, Schlenk RF.

Blood. 2014 Jun 26;123(26):4027-36. doi: 10.1182/blood-2013-12-546283. Epub 2014 May 5. Erratum in: Blood. 2015 May 7;125(19):3037.

4.

Controlled surface modification of Ti-40Nb implant alloy by electrochemically assisted inductively coupled RF plasma oxidation.

Göttlicher M, Rohnke M, Helth A, Leichtweiß T, Gemming T, Gebert A, Eckert J, Janek J.

Acta Biomater. 2013 Nov;9(11):9201-10. doi: 10.1016/j.actbio.2013.07.015. Epub 2013 Jul 25.

PMID:
23891813
5.

Langendorff heart: a model system to study cardiovascular effects of engineered nanoparticles.

Stampfl A, Maier M, Radykewicz R, Reitmeir P, Göttlicher M, Niessner R.

ACS Nano. 2011 Jul 26;5(7):5345-53. doi: 10.1021/nn200801c. Epub 2011 Jun 7.

PMID:
21630684
6.

Histone deacetylase (HDAC) 1 and 2 expression and chemotherapy in gastric cancer.

Mutze K, Langer R, Becker K, Ott K, Novotny A, Luber B, Hapfelmeier A, Göttlicher M, Höfler H, Keller G.

Ann Surg Oncol. 2010 Dec;17(12):3336-43. doi: 10.1245/s10434-010-1182-1. Epub 2010 Jun 29.

PMID:
20585871
7.

The specific role of histone deacetylase 2 in adult neurogenesis.

Jawerka M, Colak D, Dimou L, Spiller C, Lagger S, Montgomery RL, Olson EN, Wurst W, Göttlicher M, Götz M.

Neuron Glia Biol. 2010 May;6(2):93-107. doi: 10.1017/S1740925X10000049. Epub 2010 Apr 14.

PMID:
20388229
8.

Differential impact of diesel particle composition on pro-allergic dendritic cell function.

Braun A, Bewersdorff M, Lintelmann J, Matuschek G, Jakob T, Göttlicher M, Schober W, Buters JT, Behrendt H, Mempel M.

Toxicol Sci. 2010 Jan;113(1):85-94. doi: 10.1093/toxsci/kfp239. Epub 2009 Oct 4.

PMID:
19805405
9.

HDAC2 mediates therapeutic resistance of pancreatic cancer cells via the BH3-only protein NOXA.

Fritsche P, Seidler B, Schüler S, Schnieke A, Göttlicher M, Schmid RM, Saur D, Schneider G.

Gut. 2009 Oct;58(10):1399-409. doi: 10.1136/gut.2009.180711. Epub 2009 Jun 14.

PMID:
19528037
10.

IGFBP-2 overexpression reduces the appearance of dysplastic aberrant crypt foci and inhibits growth of adenomas in chemically induced colorectal carcinogenesis.

Diehl D, Hessel E, Oesterle D, Renner-Müller I, Elmlinger M, Langhammer M, Göttlicher M, Wolf E, Lahm H, Hoeflich A.

Int J Cancer. 2009 May 1;124(9):2220-5. doi: 10.1002/ijc.24193.

11.

Electrophoretic analysis of the mitochondrial outer membrane rupture induced by permeability transition.

Zischka H, Larochette N, Hoffmann F, Hamöller D, Jägemann N, Lichtmannegger J, Jennen L, Müller-Höcker J, Roggel F, Göttlicher M, Vollmar AM, Kroemer G.

Anal Chem. 2008 Jul 1;80(13):5051-8. doi: 10.1021/ac800173r. Epub 2008 May 30.

PMID:
18510346
12.

Isolation of highly pure rat liver mitochondria with the aid of zone-electrophoresis in a free flow device (ZE-FFE).

Zischka H, Lichtmannegger J, Jägemann N, Jennen L, Hamöller D, Huber E, Walch A, Summer KH, Göttlicher M.

Methods Mol Biol. 2008;424:333-48. doi: 10.1007/978-1-60327-064-9_26. Review.

PMID:
18369873
13.

Reduced body size and decreased intestinal tumor rates in HDAC2-mutant mice.

Zimmermann S, Kiefer F, Prudenziati M, Spiller C, Hansen J, Floss T, Wurst W, Minucci S, Göttlicher M.

Cancer Res. 2007 Oct 1;67(19):9047-54.

14.

Valproic acid (VPA) in patients with refractory advanced cancer: a dose escalating phase I clinical trial.

Atmaca A, Al-Batran SE, Maurer A, Neumann A, Heinzel T, Hentsch B, Schwarz SE, Hövelmann S, Göttlicher M, Knuth A, Jäger E.

Br J Cancer. 2007 Jul 16;97(2):177-82. Epub 2007 Jun 19.

15.

Flavonoids alter P-gp expression in intestinal epithelial cells in vitro and in vivo.

Lohner K, Schnäbele K, Daniel H, Oesterle D, Rechkemmer G, Göttlicher M, Wenzel U.

Mol Nutr Food Res. 2007 Mar;51(3):293-300.

PMID:
17295420
16.

TCDD induces c-jun expression via a novel Ah (dioxin) receptor-mediated p38-MAPK-dependent pathway.

Weiss C, Faust D, Dürk H, Kolluri SK, Pelzer A, Schneider S, Dietrich C, Oesch F, Göttlicher M.

Oncogene. 2005 Jul 21;24(31):4975-83.

PMID:
15897893
17.

Apoptosis on hepatoma cells but not on primary hepatocytes by histone deacetylase inhibitors valproate and ITF2357.

Armeanu S, Pathil A, Venturelli S, Mascagni P, Weiss TS, Göttlicher M, Gregor M, Lauer UM, Bitzer M.

J Hepatol. 2005 Feb;42(2):210-7.

PMID:
15664246
18.

A nuclear isoform of the focal adhesion LIM-domain protein Trip6 integrates activating and repressing signals at AP-1- and NF-kappaB-regulated promoters.

Kassel O, Schneider S, Heilbock C, Litfin M, Göttlicher M, Herrlich P.

Genes Dev. 2004 Oct 15;18(20):2518-28.

19.

Specific and redundant functions of histone deacetylases in regulation of cell cycle and apoptosis.

Zhu P, Huber E, Kiefer F, Göttlicher M.

Cell Cycle. 2004 Oct;3(10):1240-2. Epub 2004 Oct 26.

PMID:
15477762
20.

UVA inactivates protein tyrosine phosphatases by calpain-mediated degradation.

Gulati P, Markova B, Göttlicher M, Böhmer FD, Herrlich PA.

EMBO Rep. 2004 Aug;5(8):812-7. Epub 2004 Jul 9. Erratum in: EMBO Rep. 2005 Nov;6(11):1101.

21.

Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis.

Zhu P, Martin E, Mengwasser J, Schlag P, Janssen KP, Göttlicher M.

Cancer Cell. 2004 May;5(5):455-63.

22.

Valproic acid: an old drug newly discovered as inhibitor of histone deacetylases.

Göttlicher M.

Ann Hematol. 2004;83 Suppl 1:S91-2. Review.

PMID:
15124690
23.

The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2.

Krämer OH, Zhu P, Ostendorff HP, Golebiewski M, Tiefenbach J, Peters MA, Brill B, Groner B, Bach I, Heinzel T, Göttlicher M.

EMBO J. 2003 Jul 1;22(13):3411-20.

24.

The anti-inflammatory action of glucocorticoid hormones.

Herrlich P, Göttlicher M.

Ernst Schering Res Found Workshop. 2002;(40):297-304. Review. No abstract available.

PMID:
12355722
25.

Redox regulation in mammalian signal transduction.

Gulati P, Klöhn PC, Krug H, Göttlicher M, Markova B, Böhmer FD, Herrlich P.

IUBMB Life. 2001 Jul;52(1-2):25-8. Review. No abstract available.

26.

Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor.

Reichardt HM, Tuckermann JP, Göttlicher M, Vujic M, Weih F, Angel P, Herrlich P, Schütz G.

EMBO J. 2001 Dec 17;20(24):7168-73.

27.

Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells.

Göttlicher M, Minucci S, Zhu P, Krämer OH, Schimpf A, Giavara S, Sleeman JP, Lo Coco F, Nervi C, Pelicci PG, Heinzel T.

EMBO J. 2001 Dec 17;20(24):6969-78.

28.

Novel target genes of the Ah (dioxin) receptor: transcriptional induction of N-myristoyltransferase 2.

Kolluri SK, Balduf C, Hofmann M, Göttlicher M.

Cancer Res. 2001 Dec 1;61(23):8534-9.

29.

Histone deacetylase as a therapeutic target.

Krämer OH, Göttlicher M, Heinzel T.

Trends Endocrinol Metab. 2001 Sep;12(7):294-300. Review.

PMID:
11504668
30.
31.
32.

Acyl-CoA esters antagonize the effects of ligands on peroxisome proliferator-activated receptor alpha conformation, DNA binding, and interaction with Co-factors.

Elholm M, Dam I, Jorgensen C, Krogsdam AM, Holst D, Kratchmarova I, Gottlicher M, Gustafsson JA, Berge R, Flatmark T, Knudsen J, Mandrup S, Kristiansen K.

J Biol Chem. 2001 Jun 15;276(24):21410-6. Epub 2001 Feb 20.

33.
35.
36.

Radiation-induced signal transduction. Mechanisms and consequences.

Herrlich P, Bender K, Knebel A, Böhmer FD, Gross S, Blattner C, Rahmsdorf HJ, Göttlicher M.

C R Acad Sci III. 1999 Feb-Mar;322(2-3):121-5. Review.

PMID:
10196662
37.

Sequential DNA damage-independent and -dependent activation of NF-kappaB by UV.

Bender K, Göttlicher M, Whiteside S, Rahmsdorf HJ, Herrlich P.

EMBO J. 1998 Sep 1;17(17):5170-81.

38.

Transcriptional cross-talk, the second mode of steroid hormone receptor action.

Göttlicher M, Heck S, Herrlich P.

J Mol Med (Berl). 1998 Jun;76(7):480-9. Review.

PMID:
9660166
39.

Identification of IHABP, a 95 kDa intracellular hyaluronate binding protein.

Hofmann M, Fieber C, Assmann V, Göttlicher M, Sleeman J, Plug R, Howells N, von Stein O, Ponta H, Herrlich P.

J Cell Sci. 1998 Jun;111 ( Pt 12):1673-84.

40.

I kappaB alpha-independent downregulation of NF-kappaB activity by glucocorticoid receptor.

Heck S, Bender K, Kullmann M, Göttlicher M, Herrlich P, Cato AC.

EMBO J. 1997 Aug 1;16(15):4698-707.

41.

Complementation of Ah receptor deficiency in hepatoma cells: negative feedback regulation and cell cycle control by the Ah receptor.

Weiss C, Kolluri SK, Kiefer F, Göttlicher M.

Exp Cell Res. 1996 Jul 10;226(1):154-63.

PMID:
8660951
42.

Interaction of the Ubc9 human homologue with c-Jun and with the glucocorticoid receptor.

Göttlicher M, Heck S, Doucas V, Wade E, Kullmann M, Cato AC, Evans RM, Herrlich P.

Steroids. 1996 Apr;61(4):257-62.

PMID:
8733011
43.

Fatty acid activation of peroxisome proliferator-activated receptor (PPAR).

Bocos C, Göttlicher M, Gearing K, Banner C, Enmark E, Teboul M, Crickmore A, Gustafsson JA.

J Steroid Biochem Mol Biol. 1995 Jun;53(1-6):467-73. Review.

PMID:
7626496
44.

Coordinate induction of hepatic fatty acyl-CoA oxidase and P4504A1 in rat after activation of the peroxisome proliferator-activated receptor (PPAR) by sulphur-substituted fatty acid analogues.

Demoz A, Vaagenes H, Aarsaether N, Hvattum E, Skorve J, Göttlicher M, Lillehaug JR, Gibson GG, Gustafsson JA, Hood S, et al.

Xenobiotica. 1994 Sep;24(9):943-56.

PMID:
7810175
45.

Fatty acid activation of the peroxisome proliferator activated receptor, a member of the nuclear receptor gene superfamily.

Gearing KL, Göttlicher M, Widmark E, Banner CD, Tollet P, Strömstedt M, Rafter JJ, Berge RK, Gustafsson JA.

J Nutr. 1994 Aug;124(8 Suppl):1284S-1288S. doi: 10.1093/jn/124.suppl_8.1284S. Review.

PMID:
8064376
46.

Effects of fatty acids on gene expression mediated by a member of the nuclear receptor supergene family.

Gustafsson JA, Gearing K, Widmark E, Tollet P, Strömstedt M, Berge RK, Göttlicher M.

Prog Clin Biol Res. 1994;387:21-8. Review. No abstract available.

PMID:
7972247
47.

Structural and metabolic requirements for activators of the peroxisome proliferator-activated receptor.

Göttlicher M, Demoz A, Svensson D, Tollet P, Berge RK, Gustafsson JA.

Biochem Pharmacol. 1993 Dec 14;46(12):2177-84.

PMID:
8274151
50.

Interaction of the peroxisome-proliferator-activated receptor and retinoid X receptor.

Gearing KL, Göttlicher M, Teboul M, Widmark E, Gustafsson JA.

Proc Natl Acad Sci U S A. 1993 Feb 15;90(4):1440-4.

Supplemental Content

Loading ...
Support Center